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1. Introduction
Multicellular life evolved in the presence of microorganisms and
formed complex associations with their microbiota, the sum of
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all associated archaea, bacteria, fungi, and viruses. These associ-
ations greatly aﬀect the health and life history of the host, which
led to a new understanding of “self” and establishment of the
“metaorganism” concept.[1] The Collaborative Research Centre
(CRC) 1182 aims at elucidating the evolution and function of
metaorganisms. Its annual conference, the Young Investigator
Research Day (YIRD), serves as a platform for scientists of vari-
ous disciplines to share novel ﬁndings on host–microbiota inter-
actions, thereby providing a comprehensive overview of recent
developments and new directions in metaorganism research.
Even though we have gained tremendous insights into the com-
position and dynamics of host-associated microbial communi-
ties and their correlations with host health and disease, it also
became evident that moving from correlative toward functional
studies is needed to examine the underlying mechanisms of in-
teractions within the metaorganism. Non-classical model organ-
isms in particular possess signiﬁcant potential to functionally
address many open questions in metaorganism research. Here,
we suggest and introduce a roadmapmoving from correlation to-
ward a functional understanding of host–microbiota interactions
and highlight its potential in emerging ecological, agricultural,
and translational medical applications.
2. Approaches toward a Functional Understanding
of Metaorganisms
Upon identiﬁcation of a potential host–microbiota interaction,
functional proﬁling must address who is doing what, how, when,
and where. “Who” refers to the precise identiﬁcation of both host
andmicrobial partners. “What” denotes the phenotypic impact of
microorganisms on their associated host and vice versa. “How”
refers to the process and the involved molecules. “When” and
“where” denote the spatial and temporal dynamics. Metaorgan-
ism function can be analyzed in three scales: potential, active,
and realized function.[2] Potential function is assessed by ana-
lyzing genomes. Active function studies exploit transcriptomes,
proteomes, and metabolomes. Realized function is measured by
examining the phenotype. To foster an integrative view ofmetaor-
ganism function, future eﬀorts should address all three scales
(Figure 1). Gnotobiotic model systems, in which all associated
entities of a metaorganism are known and accounted for, lay the
foundation of functional studies in host–microbiota interactions,
together with the isolation and cultivation of microorganisms.
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Figure 1. Roadmap toward a functional understanding of metaorganisms. At the organismal scale, the individual host and microbial partners may
be separated to study them individually and to create custom microbiota assemblies to understand the contribution of the particular entities. At the
molecular scale, several “omics” methodologies including genomics, proteomics, or metabolomics may be employed. These approaches are especially
crucial for model systems, where interacting partners cannot be separated yet. Through bioinformatic analysis and mathematical modeling, potential
candidates can be identiﬁed and new hypotheses can be developed. Ultimately, metaorganismsmay be studied functionally using genetic, environmental,
or pharmaco-chemical manipulations. Extending our understanding of the metaorganism will aid in improving agricultural and medical practices. Since
most studies this far focused only on bacteria, there is a vast knowledge gap in the understanding of neglected partners within the microbiota such as
algae, archaea, fungi, protists, and viruses.
Germ-free hosts, that is, plants or animals without any associated
microorganisms, represent the most reduced form of a gnotobi-
otic system enabling to assess the functional capacity of the host
in the absence of a microbiota. Subsequent exposure of germ-
free individuals to a single microbial strain or a chosen set of
microorganisms provides a platform where the impact of each
microbial component on the host can be studied separately.
These chosen sets of microorganisms can be developed as stan-
dardized minimal reference microbiota,[3] that not only reduces
the complexity compared to a full regular microbiota and thereby
promote functional analyses, but also facilitate comparisons
across experiments and laboratories or animal facilities. There-
fore, eﬀorts should be undertaken to develop newly emerging
animal and plant model systems for metaorganism research
as gnotobiotic along with suitable standardized minimal
microbiota, akin to the “Oligo-Mouse-Microbiota”.[3] However,
one has to bear in mind that host–microbiota interactions are far
more complex than direct links between isolated partners. Thus,
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intact metaorganism functionality may be compromised in these
minimal communities. Experiments with animals harboring
“wild” microbiota demonstrated signiﬁcantly altered physio-
logical responses compared to standardized lab microbiota,[4]
demonstrating the importance of these types of reconstituted
models. To further characterize the molecular mechanisms of
host–microbiota interactions, gnotobiotic models ideally are
supplemented by genetic manipulations of both the host and
its microbiota, for example, using genome editing or RNA-
interference. With the advent of genome editing technologies
like CRISPR-Cas9 we anticipate that in the upcoming years
many more model systems will be genetically modiﬁable. Mean-
while in genetically inaccessible systems, pharmacochemical
interference methods may be used to target the candidate genes
or pathways instead.
The rapid development of high-throughput and high-
resolution analytical techniques also fostered the functional pro-
ﬁling of host–microbiota interactions, especially in the absence
of gnotobiotic model systems. Next-generation-sequencing-
based amplicon (e.g., 16S, internal transcribed spacer (ITS)),
metagenome and epigenome analyses allow the revelation of the
identity of individual partners and their functional potentials. In
contrast, metatranscriptomics and metaproteomics expose snap-
shots of cellular expression activities, whereas metabolomics
reveals actual metabolites within metaorganisms. By using
longitudinal multiomics studies, individual entities (e.g., strains,
species, cell types of the host or microbiota) along with genes
and molecules or chemical modiﬁcations can be identiﬁed that
coordinate the host–microbiota interactions and phenotypes.[5]
Systems biology and mathematical modeling of these multiomic
data represent another important cornerstone of metaorganism
research. Modeling-assisted prediction of host–microbiota inter-
actions have the potential to guide experimental identiﬁcation
of metabolites and metabolic pathways or to generate new
metaorganism concepts.[6] Study design is crucial to identify
functional alterations in the metaorganism using multiomics.
Longitudinal studies allow the identiﬁcation of shifts in the mi-
crobiota due a treatment (e.g., therapy) or before disease onset,
ruling out disease-dependent confounding or secondary eﬀects.
However, all microbial species, candidate genes, or molecules
identiﬁed by “omics” technologies ultimately require validation
by in vitro or in vivo assays, which, until recently, have largely
been missing in metaorganism studies. As a side note, the
spatial pattern of environmental factors, microorganisms and
molecules are often neglected, but these are crucial drivers of
metaorganism physiology.[7] Performing “omics” on intact spec-
imen averages over the complete sample may mask important
and functionally relevant diﬀerences. Thus, technologies that
facilitate local, site-speciﬁc analyses may reveal novel insights
into host–microbiota interactions and thus should be employed
more frequently. For example, high-resolution imaging coupled
to physical or chemical labeling such as matrix-assisted laser
desorption/ionization (MALDI) imaging mass spectrometry
can be coupled with macroscale community dynamics on the
host to better understand how microorganisms aﬀect speciﬁc
host functions. Additionally, in particular single-cell “omics”
(e.g., scRNA-seq, scATAC-seq) has the potential to improve
our understanding of metaorganisms at an unprecedented
resolution.
3. Novel Model Metaorganisms Extend Our
Functional Understanding of Host–Microbiota
Interactions
Most research on host–microbiota interactions is being per-
formed in established model organisms such as the plant
Arabidopsis, mice, the fruit ﬂyDrosophila, or the wormCaenorhab-
ditis. However, their complexity or inability to assess certain phys-
iological traits, for example, due to genetic redundancies or long
generation times, limit their range of studying host–microbiota
interactions. Novel model systems are capable of bridging these
gaps, as demonstrated by recent studies comparing the micro-
biota of a wide range of diﬀerent metaorganisms. First, Bdellovib-
rio and like organisms (BALO), a group of predatory bacteria,
were identiﬁed in various metaorganisms as potential drivers
of microbiota diversity, thereby alleviating dysbiosis and pro-
moting host ﬁtness.[8] Second, application of a neutral model to
the microbiota composition in diﬀerent host organisms revealed
that microbiota community structure is generally consistent with
neutral expectations and suggested that transient deviations from
neutrality play a role in various diseases.[9] Third, a large scale
metagenomics study revealed that the transition from aquatic
to a terrestrial habitat marked a major event in the evolution of
host-associated microbiota.[10] Finally, using basal metazoans as
model systems enabled the recent elucidation of important con-
ceptual andmolecular advances for host–microbiota interactions.
In the cnidarian Hydra, the importance of phages for maintain-
ing a homeostatic equilibrium among diﬀerent host-associated
bacteria was uncovered, which was only possible due to the avail-
ability of gnotobiotic culture, the reduced complexity of its asso-
ciated microbiota, isolation and culture of the members of the
microbiota, and mathematical modeling approaches.[11] Taken
together, these examples demonstrate the value of using a wide
array of novel and well-suited metaorganism model systems to
elucidate functional interactions between hosts and their associ-
ated microbiota.
4. A Deeper Functional Understanding of
Metaorganisms Will Improve Agriculture and
Disease Therapies
From plants to humans, one key function of the microbiota
within the metaorganism is the protection against pathogens.
In plants, the combinatorial action of two processes forms the
ﬁrst line of defense. First, the natural soil microbiota antagonizes
pathogen colonization. Second, the plant releases organic com-
pounds from its roots that actively recruit and enrich speciﬁc
microorganisms. Pantoea agglomerans is a plant root-associated
bacterium that forms a symbiotic relationship with its host. Pan-
toea promotes growth of its host plant through several mecha-
nisms. These include the secretion of phytohormones, solubi-
lization of otherwise inaccessible nutrients, and suppression of
pathogen growth.[12] Pantoea colonizes a variety of plant hosts in-
cluding the common domesticated wheat. Colonization of wheat
plants with strains of Pantoea reduces susceptibility for infection
by pathogenic fungi. Therefore, strains of Pantoea are now com-
mercially utilized as biofertilizer in agriculture with the aim to
improve plant growth and to reduce pathogenic infection rates.[12]
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To prevent mass extinction similar eﬀorts could be applied to
other economically important plant species that are at risk due to
pathogen epidemics (e.g., banana) facilitated by the vast mono-
cultures in modern agriculture.
In humans, a plethora of descriptive studies associated dys-
biosis, which generally describes deviations in the commensal
microbial community from the normal healthy conformation,
with many diseases including inﬂammatory bowel disease, can-
cer, obesity, diabetes, and even mental health issues. Yet, only a
small fraction of studies moved beyond correlations by employ-
ing microbiota-directed manipulations to test for their eﬀects on
metaorganism function. An elegant way to test the functional rel-
evance of dysbiotic microbiota signatures is via fecal microbiota
transplantation (FMT). It is the process of transplanting fecal bac-
teria from one individual into a recipient subject. One option is
to transplant the dysbiotic microbiota of a diseased patient into
a healthy recipient (animal model) to test whether the disease
phenotype can be transferred along with the microbiota and to
identify the disease-causing entity. This option should be used
more frequently in upcoming studies to improve our functional
understanding of the metaorganism. An alternative FMT option
is to transplant themicrobiota of a healthy subject into a diseased
patient with the goal of overcoming dysbiosis and to abrogate dis-
ease symptoms. Both FMT options are now being increasingly
used for functional microbiota characterization and therapy at-
tempts in humans. The most common therapeutic application
is to treat widespread infections with Clostridium diﬃcile, which
causes chronic diarrhea, potentially leading to death by dehydra-
tion and exhaustion. FMT successfully clears C. diﬃcile infec-
tions with over 90% eﬃcacy, yet also poses major challenges and
limitations. So far we do not understand the molecular or eco-
logical interactions between the donor and recipient microbiota
to safely predict the FMT outcome. This is exempliﬁed by a re-
cent study,[13] where the transfer of a sterile stool ﬁltrate alone
successfully cleared C. diﬃcile infection, suggesting that micro-
bial metabolites or bacteriophages may play an important role
in FMT outcomes. Furthermore, even with existing safety mea-
sures, FMT treatments have also already resulted in adverse ef-
fects for some patients. This is especially concerning since some
members of the microbiota, which are normally harmless, have
the potential to take on pathogenic traits under certain condi-
tions, for example, upon transfer to a new host after FMT. How-
ever, which factors drive the pathogenic transformation of those
pathobionts remains unclear. Thus, it is imperative to improve
our functional understanding of the human gut microbiota and
of themechanismsmaintaining healthy host–microbiota interac-
tions to improve FMT safety and eﬃcacy. Identifying those spe-
ciﬁc microorganisms capable of rescuing the disease phenotype
could lead to the development of synthetic minimal microbiota
to be used for safe and reproducible FMT treatments.
A large body of metaorganism studies in the last decade
has changed our view of the individual host and provided im-
portant clues for microbial factors inﬂuencing health and dis-
ease. However, most of these studies were correlative, generating
associations between entities of the microbiota and physiological
processes of the metaorganism, and still require functional val-
idation. We therefore call to move beyond correlation and focus
on functional proﬁling of metaorganisms, which is now possible
due to methodological advances such as longitudinal multiomics
and novel metaorganism model systems. Finally, as most mi-
crobiota research focused on bacteria, we suggest moving other
entities of the microbiota such as archaea, viruses and small eu-
karyotes, that potentially are equally important formetaorganism
function, more into the spotlight. Improving our functional un-
derstanding of the complex host–microbiota interactions within
metaorganisms will not only reveal deeper insights into the bi-
ology and ecology of life on Earth, but also promote the de-
velopment of novel therapeutics against microbiota-associated
diseases in a variety of organisms—from plants to humans.
Acknowledgements
The authors thank all the participants of the YIRD 2019, in particular the
guest speakers Dr.Mary BethDecker and Prof. Paul Turner (Yale University,
Connecticut, USA) for insightful presentations and stimulating discus-
sions. The YIRD and research in our laboratories were partially funded by
Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Re-
search Centre (CRC) 1182 “Origin and Function of Metaorganisms.” The
authors especially thank Prof. Thomas Bosch for supporting the YIRD and
junior researchers of the CRC 1182. Additionally, the authors acknowledge
support by the Excellence Cluster “Inﬂammation at Interfaces” (EXC306)
to F.S. and G.M., the Excellence Cluster “Precision Medicine in Chronic In-
ﬂammation” (EXS 2167), the Research Training Group “Genes, Environ-
ment, and Inﬂammation” (RTG 1743) to F.S. and the Villum and Velux
Foundations (grant 00025512) to C.J.
Conﬂict of Interest
The authors declare no conﬂict of interest.
Author Contributions
C.J. and F.S. are shared seniors authors. J.L., G.M., J.B., D.H., and R.S. are
shared second authors.
Keywords
functional understanding, host–microbiota interaction, metaorganism,
novel model organisms
Received: November 8, 2019
Published online:
[1] T. Rees, T. Bosch, A. E. Douglas, PLoS Biol. 2018, 16, e2005358.
[2] A. T. Reese, S. M. Kearney, Curr. Opin. Microbiol. 2019, 50, 20.
[3] S. Brugiroux, M. Beutler, C. Pfann, D. Garzetti, H. J. Ruscheweyh, D.
Ring, M. Diehl, S. Herp, Y. Lotscher, S. Hussain, B. Bunk, R. Pukall, D.
H. Huson, P. C. Munch, A. C. McHardy, K. D. McCoy, A. J. Macpher-
son, A. Loy, T. Clavel, D. Berry, B. Stecher, Nat. Microbiol. 2017, 2,
16215.
[4] S. P. Rosshart, J. Herz, B. G. Vassallo, A. Hunter, M. K. Wall, J. H.
Badger, J. A.McCulloch, D. G. Anastasakis, A. A. Sarshad, I. Leonardi,
N. Collins, J. A. Blatter, S. J. Han, S. Tamoutounour, S. Potapova, M.
B. Foster St Claire,W. Yuan, S. K. Sen,M. S. Dreier, B. Hild,M.Hafner,
D. Wang, I. D. Iliev, Y. Belkaid, G. Trinchieri, B. Rehermann, Science
2019, 365, eaaw4361.
BioEssays 2019, 1900211 © 2019 The Authors. BioEssays published by Wiley Periodicals, Inc1900211 (4 of 5)
www.advancedsciencenews.com www.bioessays-journal.com
[5] W. Zhou,M. R. Sailani, K. Contrepois, Y. Zhou, S. Ahadi, S. R. Leopold,
M. J. Zhang, V. Rao,M. Avina, T.Mishra, J. Johnson, B. Lee-McMullen,
S. Chen, A. A. Metwally, T. D. B. Tran, H. Nguyen, X. Zhou, B. Al-
bright, B. Y. Hong, L. Petersen, E. Bautista, B. Hanson, L. Chen, D.
Spakowicz, A. Bahmani, D. Salins, B. Leopold,M. Ashland, O. Dagan-
Rosenfeld, S. Rego, et al., Nature 2019, 569, 663.
[6] R. Pryor, P. Norvaisas, G. Marinos, L. Best, L. B. Thingholm, L. M.
Quintaneiro, W. De Haes, D. Esser, S. Waschina, C. Lujan, R. L.
Smith, T. A. Scott, D. Martinez-Martinez, O. Woodward, K. Bryson,
M. Laudes, W. Lieb, R. H. Houtkooper, A. Franke, L. Temmerman, I.
Bjedov, H. M. Cocheme, C. Kaleta, F. Cabreiro, Cell 2019, 178, 1299.
[7] F. Sommer, F. Bäckhed, BioEssays 2016, 38, 455.
[8] J. Johnke, S. Fraune, T. C. G. Bosch, U. Hentschel, H. Schulenburg,
Microb. Ecol. 2019, 1.
[9] M. Sieber, L. Pita, N. Weiland-Brauer, P. Dirksen, J. Wang, B.
Mortzfeld, S. Franzenburg, R. A. Schmitz, J. F. Baines, S. Fraune,
U. Hentschel, H. Schulenburg, T. C. G. Bosch, A. Traulsen, PLoS Biol.
2019, 17, e3000298.
[10] P. Rausch, M. Ruhlemann, B. M. Hermes, S. Doms, T. Dagan, K.
Dierking, H. Domin, S. Fraune, J. von Frieling, U. Hentschel, F. A.
Heinsen, M. Hoppner, M. T. Jahn, C. Jaspers, K. A. B. Kissoyan, D.
Langfeldt, A. Rehman, T. B. H. Reusch, T. Roeder, R. A. Schmitz,
H. Schulenburg, R. Soluch, F. Sommer, E. Stukenbrock, N. Weiland-
Brauer, P. Rosenstiel, A. Franke, T. Bosch, J. F. Baines, Microbiome
2019, 7, 133.
[11] X. Y. Li, T. Lachnit, S. Fraune, T. C. G. Bosch, A. Traulsen, M. Sieber,
J. R. Soc., Interface 2017, 14, 20170563.
[12] J. V. Shariati, M. A. Malboobi, Z. Tabrizi, E. Tavakol, P. Owilia, M. Sa-
fari, Sci. Rep. 2017, 7, 15610.
[13] S. J. Ott, G. H. Waetzig, A. Rehman, J. Moltzau-Anderson, R. Bharti, J.
A. Grasis, L. Cassidy, A. Tholey, H. Fickenscher, D. Seegert, P. Rosen-
stiel, S. Schreiber, Gastroenterology 2016, 152, 799.
BioEssays 2019, 1900211 © 2019 The Authors. BioEssays published by Wiley Periodicals, Inc1900211 (5 of 5)
